Chinese anti-coronary heart disease medicine overseas market overview（中国anti-coronary心脏病医学海外市场概述）.doc

Chinese anti-coronary heart disease medicine overseas market overview [Keywords] anti-coronary heart disease Chinese medicine Abstract: In the current situation and prospects of the development of natural medicine market, the EU lt;lt; bottleneck of traditional medicines bill strict restrictions gt;gt; on the export of Chinese medicine and Chinese medicine to enter the European and American markets and domestic anti-coronary heart disease Chinese medicine overseas sales overview. Keywords: natural medicine, anti-coronary heart disease medicine overseas markets Abstract: The market size and potential for the natural medicines was reviewed in this paper; the impact of EU Directive on Traditional Herbal Medicinal Products and the bottleneck for the export of traditional Chinese medicine was analyzed; and the overseas markets of leading traditional Chinese medicines for coronary heart disease were introduced. Keywords:: natural medicine, traditional Chinese medicine for coronary heart disease, overseas market The status and prospects of the development of an international natural medicine market Currently, the international natural medicine, herbal medicine are no uniform clear definition on the general, natural medicine refers broadly without specific chemical modification, and does not contain chemical ingredients to the nature of existing substances including plant, animal, mineral, or their extracts as functional components, the product has a therapeutic effect or health function where herbal medicine is an important part in the natural medicine natural medicine market in overlord-class products, such as ginkgo, ginseng, Hypericum perforatum, Echinacea, chrysanthemum and other, without exception, are botanicals. these products relative to a single plant sources to determine on their mechanism of action as well as the efficacy of scientific abundant definitely and its research and development and has a long history. U.S. Food and Drug Admini